1. Home
  2. SNGX vs HAO Comparison

SNGX vs HAO Comparison

Compare SNGX & HAO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNGX
  • HAO
  • Stock Information
  • Founded
  • SNGX 1987
  • HAO 2018
  • Country
  • SNGX United States
  • HAO China
  • Employees
  • SNGX N/A
  • HAO 30
  • Industry
  • SNGX Biotechnology: Pharmaceutical Preparations
  • HAO
  • Sector
  • SNGX Health Care
  • HAO
  • Exchange
  • SNGX Nasdaq
  • HAO NYSE
  • Market Cap
  • SNGX 7.4M
  • HAO 6.6M
  • IPO Year
  • SNGX 1987
  • HAO 2024
  • Fundamental
  • Price
  • SNGX $2.39
  • HAO $2.00
  • Analyst Decision
  • SNGX
  • HAO
  • Analyst Count
  • SNGX 0
  • HAO 0
  • Target Price
  • SNGX N/A
  • HAO N/A
  • AVG Volume (30 Days)
  • SNGX 44.9K
  • HAO 7.0M
  • Earning Date
  • SNGX 03-14-2025
  • HAO 10-29-2024
  • Dividend Yield
  • SNGX N/A
  • HAO N/A
  • EPS Growth
  • SNGX N/A
  • HAO 20.20
  • EPS
  • SNGX N/A
  • HAO 0.04
  • Revenue
  • SNGX $364,183.00
  • HAO $48,519,836.00
  • Revenue This Year
  • SNGX N/A
  • HAO N/A
  • Revenue Next Year
  • SNGX $76.64
  • HAO N/A
  • P/E Ratio
  • SNGX N/A
  • HAO $2.47
  • Revenue Growth
  • SNGX N/A
  • HAO 71.88
  • 52 Week Low
  • SNGX $1.83
  • HAO $0.09
  • 52 Week High
  • SNGX $14.88
  • HAO $10.60
  • Technical
  • Relative Strength Index (RSI)
  • SNGX 43.83
  • HAO 61.24
  • Support Level
  • SNGX $2.25
  • HAO $1.75
  • Resistance Level
  • SNGX $2.60
  • HAO $2.02
  • Average True Range (ATR)
  • SNGX 0.15
  • HAO 0.35
  • MACD
  • SNGX 0.03
  • HAO -0.06
  • Stochastic Oscillator
  • SNGX 52.27
  • HAO 11.03

About SNGX Soligenix Inc.

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).

About HAO HAOXI HEALTH TECHNOLOGY LTD

Haoxi Health Technology Ltd is an online marketing solution provider in China, with an advertiser client base mainly in the healthcare industry. Haoxi has been rooted in the field of local online effect marketing for many years, serving customers in various industries at home and abroad, and its main business is the medical industry. It generates its revenue by providing one-stop online marketing solutions, in particular online short video marketing solutions, to advertisers through its media partners. The company provides customized marketing solutions by planning, producing, placing, and optimizing online ads, especially online short video ads, to help its advertisers acquire, convert, and retain ultimate consumers on various online media platforms.

Share on Social Networks: